Medical Facilities Croissance future
Future contrôle des critères 0/6
Les revenus et les bénéfices de Medical Facilities devraient diminuer respectivement de 14.3% et de 30% par an, tandis que le BPA devrait croître de diminuer de 29.1% par an.
Informations clés
-30.0%
Taux de croissance des bénéfices
-29.1%
Taux de croissance du BPA
Healthcare croissance des bénéfices | 61.1% |
Taux de croissance des recettes | -14.3% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 15 Nov 2024 |
Mises à jour récentes de la croissance future
Recent updates
Medical Facilities' (TSE:DR) Earnings Offer More Than Meets The Eye
Nov 15Medical Facilities (TSE:DR) Is Paying Out A Dividend Of $0.09
Jun 19We Think Medical Facilities' (TSE:DR) Robust Earnings Are Conservative
Mar 22Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Nov 12Medical Facilities (TSE:DR) Seems To Use Debt Quite Sensibly
Aug 05Medical Facilities' (TSE:DR) Dividend Will Be $0.0805
Mar 26Medical Facilities (TSE:DR) Has Affirmed Its Dividend Of $0.0805
Dec 23Is Medical Facilities (TSE:DR) Using Too Much Debt?
Sep 14Is It Too Late To Consider Buying Medical Facilities Corporation (TSE:DR)?
May 13The Returns At Medical Facilities (TSE:DR) Aren't Growing
Apr 24Medical Facilities' (TSE:DR) Upcoming Dividend Will Be Larger Than Last Year's
Dec 21Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07
Sep 24Is Medical Facilities (TSE:DR) Using Too Much Debt?
Jul 24Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07
Jun 25Here's Why It's Unlikely That Medical Facilities Corporation's (TSE:DR) CEO Will See A Pay Rise This Year
May 07Is Now The Time To Look At Buying Medical Facilities Corporation (TSE:DR)?
Apr 19Here's How We Evaluate Medical Facilities Corporation's (TSE:DR) Dividend
Mar 29Medical Facilities (TSE:DR) Has A Somewhat Strained Balance Sheet
Mar 08Are Medical Facilities' (TSE:DR) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 18Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 340 | N/A | N/A | N/A | 1 |
12/31/2025 | 338 | 13 | N/A | N/A | 2 |
12/31/2024 | 428 | 19 | N/A | N/A | 2 |
9/30/2024 | 441 | 20 | 74 | 81 | N/A |
6/30/2024 | 442 | 12 | 59 | 75 | N/A |
3/31/2024 | 445 | 16 | 63 | 78 | N/A |
12/31/2023 | 446 | 19 | 57 | 73 | N/A |
9/30/2023 | 443 | 5 | 52 | 70 | N/A |
6/30/2023 | 440 | -5 | 58 | 68 | N/A |
3/31/2023 | 433 | 8 | 56 | 64 | N/A |
12/31/2022 | 425 | -4 | 50 | 57 | N/A |
9/30/2022 | 416 | 8 | 58 | 63 | N/A |
6/30/2022 | 410 | 15 | 58 | 64 | N/A |
3/31/2022 | 405 | 4 | 59 | 67 | N/A |
12/31/2021 | 399 | 16 | 67 | 76 | N/A |
9/30/2021 | 395 | 2 | 67 | 75 | N/A |
6/30/2021 | 395 | 9 | 76 | 85 | N/A |
3/31/2021 | 365 | 4 | 112 | 118 | N/A |
12/31/2020 | 364 | 11 | 106 | 113 | N/A |
9/30/2020 | 371 | 36 | 101 | 109 | N/A |
6/30/2020 | 371 | 39 | 93 | 103 | N/A |
3/31/2020 | 397 | 62 | 61 | 72 | N/A |
12/31/2019 | 398 | 44 | 65 | 77 | N/A |
9/30/2019 | 367 | 31 | 63 | 78 | N/A |
6/30/2019 | 374 | 28 | 62 | 79 | N/A |
3/31/2019 | 387 | 11 | 59 | 80 | N/A |
12/31/2018 | 391 | 23 | 60 | 81 | N/A |
9/30/2018 | 420 | 23 | 63 | 83 | N/A |
6/30/2018 | 404 | 18 | N/A | 79 | N/A |
3/31/2018 | 394 | 25 | N/A | 85 | N/A |
12/31/2017 | 385 | 21 | N/A | 80 | N/A |
9/30/2017 | 382 | 38 | N/A | 79 | N/A |
6/30/2017 | 372 | 35 | N/A | 88 | N/A |
3/31/2017 | 353 | 15 | N/A | 76 | N/A |
12/31/2016 | 339 | 10 | N/A | 78 | N/A |
9/30/2016 | 321 | -5 | N/A | 82 | N/A |
6/30/2016 | 316 | 6 | N/A | 72 | N/A |
3/31/2016 | 312 | 9 | N/A | 82 | N/A |
12/31/2015 | 309 | 25 | N/A | 80 | N/A |
9/30/2015 | 301 | 8 | N/A | 84 | N/A |
6/30/2015 | 303 | 22 | N/A | 88 | N/A |
3/31/2015 | 300 | 39 | N/A | 86 | N/A |
12/31/2014 | 297 | 19 | N/A | 88 | N/A |
9/30/2014 | 305 | 33 | N/A | 92 | N/A |
6/30/2014 | 303 | 17 | N/A | 90 | N/A |
3/31/2014 | 306 | 9 | N/A | 84 | N/A |
12/31/2013 | 309 | 11 | N/A | 86 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Les bénéfices de DR devraient diminuer au cours des 3 prochaines années ( -30% par an).
Bénéfices vs marché: Les bénéfices de DR devraient diminuer au cours des 3 prochaines années ( -30% par an).
Croissance élevée des bénéfices: Les bénéfices de DR devraient baisser au cours des trois prochaines années.
Chiffre d'affaires vs marché: Les revenus de DR devraient diminuer au cours des 3 prochaines années ( -14.3% par an).
Croissance élevée des revenus: Les revenus de DR devraient diminuer au cours des 3 prochaines années ( -14.3% par an).
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de DR devrait être élevé dans 3 ans